Natco Pharma launches Chlorantraniliprole formulated product NATGEN

26 Sep 2022 , 09:18 AM

Natco Pharma Limited informed to the exchanges that it has launched Chlorantraniliprole (CTPR) 18.5% SC under the Brand Name of NATGEN in Indian Market.

According to the regulatory filing, NATCO estimates the current market size of CTPR containing products in India to be over Rs2000 crore, the company said.

At around 9:18 AM, Natco Pharma Ltd is currently trading at Rs620.40 per share down by Rs2.7 or 0.43% from its previous closing of Rs623.10 per share on the BSE.

For feedback and suggestions, write to us at [e-mail]